S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:IRTC

iRhythm Technologies (IRTC) Stock Forecast, Price & News

$132.99
-0.02 (-0.02%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$126.08
$138.65
50-Day Range
$113.87
$168.01
52-Week Range
$41.66
$169.54
Volume
268,762 shs
Average Volume
396,223 shs
Market Capitalization
$3.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.24
30 days | 90 days | 365 days | Advanced Chart
Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

iRhythm Technologies logo

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,700
Year Founded
N/A

Sales & Book Value

Annual Sales
$322.83 million
Book Value
$8.22 per share

Profitability

Net Income
$-101.36 million
Pretax Margin
-36.34%

Debt

Price-To-Earnings

Miscellaneous

Free Float
29,301,000
Market Cap
$3.96 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/05/2022
Today
5/21/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.04 out of 5 stars

Medical Sector

548th out of 1,416 stocks

Surgical & Medical Instruments Industry

66th out of 138 stocks

Analyst Opinion: 2.4Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -













iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

Is iRhythm Technologies a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 1 sell rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" iRhythm Technologies stock.
View analyst ratings for iRhythm Technologies
or view top-rated stocks.

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for iRhythm Technologies
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its quarterly earnings data on Thursday, May, 5th. The company reported ($0.80) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.06) by $0.26. The business earned $92.40 million during the quarter, compared to analysts' expectations of $86.76 million. iRhythm Technologies had a negative net margin of 36.43% and a negative trailing twelve-month return on equity of 34.55%. The business's quarterly revenue was up 24.4% on a year-over-year basis. During the same period last year, the business earned ($0.95) earnings per share.
View iRhythm Technologies' earnings history
.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $410.00 million-$420.00 million, compared to the consensus revenue estimate of $407.15 million.

What price target have analysts set for IRTC?

9 equities research analysts have issued 1-year target prices for iRhythm Technologies' shares. Their forecasts range from $105.00 to $192.00. On average, they expect iRhythm Technologies' share price to reach $156.82 in the next year. This suggests a possible upside of 17.9% from the stock's current price.
View analysts' price targets for iRhythm Technologies
or view top-rated stocks among Wall Street analysts.

Who are iRhythm Technologies' key executives?
iRhythm Technologies' management team includes the following people:
  • Mr. Quentin S. Blackford, Pres, CEO & Director (Age 43, Pay $671.81k)
  • Mr. Douglas J. Devine, COO, CFO & Sec. (Age 52, Pay $1.14M) (LinkedIn Profile)
  • Mr. Mark J. Day Ph.D., Chief Technology Officer (Age 51, Pay $718.76k)
  • Mr. Daniel G. Wilson, Exec. VP of Strategy, Corp. Devel. & Investor Relations (Age 40, Pay $670.09k)
  • Mr. David A. Vort, Chief Commercial Officer (Age 56, Pay $896.16k)
  • Mr. Patrick Michael Murphy J.D., Chief Legal Officer (Age 43)
  • Ms. Judith C. Lenane MHA, RN, Chief Clinical Officer & Exec. VP of Products (Age 63)
  • Ms. Dietra N. Jones, Exec. VP of Clinical Operations
  • Mr. Mazi Kiani, Sr. VP of Quality & Regulatory
What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies CEO Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Square (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Sands Capital Management LLC (10.15%), Vanguard Group Inc. (9.11%), BlackRock Inc. (7.03%), Capital Research Global Investors (4.74%), Mackenzie Financial Corp (3.95%) and Invesco Ltd. (2.70%). Company insiders that own iRhythm Technologies stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies
.

Which institutional investors are selling iRhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Wellington Management Group LLP, Vident Investment Advisory LLC, Bank of New York Mellon Corp, Blair William & Co. IL, Eversept Partners LP, Sands Capital Management LLC, and State Street Corp. Company insiders that have sold iRhythm Technologies company stock in the last year include Daniel G Wilson, David A Vort, Douglas Devine, and Kevin M King.
View insider buying and selling activity for iRhythm Technologies
or view top insider-selling stocks.

Which institutional investors are buying iRhythm Technologies stock?

IRTC stock was bought by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Capital Research Global Investors, Atika Capital Management LLC, Eminence Capital LP, Goldman Sachs Group Inc., Assenagon Asset Management S.A., Invesco Ltd., and Lisanti Capital Growth LLC.
View insider buying and selling activity for iRhythm Technologies
or or view top insider-buying stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $132.99.

How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of $3.96 billion and generates $322.83 million in revenue each year. The company earns $-101.36 million in net income (profit) each year or ($4.210010) on an earnings per share basis.

How many employees does iRhythm Technologies have?

iRhythm Technologies employs 1,700 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is www.irhythmtech.com.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at (415) 632-5700 or via email at [email protected].

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.